Literature DB >> 36129422

Is Rechallenge Appropriate in Patients that Develop Immune Checkpoint Inhibitor-Associated AKI?: COMMENTARY.

Anushree C Shirali1.   

Abstract

Entities:  

Keywords:  acute kidney injury; acute kidney injury and ICU nephrology; drug toxicity; immune checkpoint inhibitors; immunotherapy; onco-nephrology

Mesh：

Substances：

Year:  2021        PMID： 36129422      PMCID： PMC9438420          DOI： 10.34067/KID.0005592021

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  12 in total

Review 1.  Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.

Authors:  Michael A Postow; Robert Sidlow; Matthew D Hellmann
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

2.  NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.

Authors:  John A Thompson; Bryan J Schneider; Julie Brahmer; Stephanie Andrews; Philippe Armand; Shailender Bhatia; Lihua E Budde; Luciano Costa; Marianne Davies; David Dunnington; Marc S Ernstoff; Matthew Frigault; Benjamin H Kaffenberger; Matthew Lunning; Suzanne McGettigan; Jordan McPherson; Nisha A Mohindra; Jarushka Naidoo; Anthony J Olszanski; Olalekan Oluwole; Sandip P Patel; Nathan Pennell; Sunil Reddy; Mabel Ryder; Bianca Santomasso; Scott Shofer; Jeffrey A Sosman; Yinghong Wang; Ryan M Weight; Alyse Johnson-Chilla; Griselda Zuccarino-Catania; Anita Engh
Journal:  J Natl Compr Canc Netw       Date:  2020-03       Impact factor: 11.908

3.  Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center.

Authors:  Troy Z Horvat; Nelly G Adel; Thu-Oanh Dang; Parisa Momtaz; Michael A Postow; Margaret K Callahan; Richard D Carvajal; Mark A Dickson; Sandra P D'Angelo; Kaitlin M Woo; Katherine S Panageas; Jedd D Wolchok; Paul B Chapman
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

4.  Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients.

Authors:  Anushree C Shirali; Mark A Perazella; Scott Gettinger
Journal:  Am J Kidney Dis       Date:  2016-04-22       Impact factor: 8.860

5.  Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors.

Authors:  Frank B Cortazar; Kristen A Marrone; Megan L Troxell; Kenneth M Ralto; Melanie P Hoenig; Julie R Brahmer; Dung T Le; Evan J Lipson; Ilya G Glezerman; Jedd Wolchok; Lynn D Cornell; Paul Feldman; Michael B Stokes; Sarah A Zapata; F Stephen Hodi; Patrick A Ott; Michifumi Yamashita; David E Leaf
Journal:  Kidney Int       Date:  2016-06-07       Impact factor: 10.612

Review 6.  Cardiorenal complications of immune checkpoint inhibitors.

Authors:  Krishna Sury; Mark A Perazella; Anushree C Shirali
Journal:  Nat Rev Nephrol       Date:  2018-09       Impact factor: 28.314

Review 7.  Association of Steroids use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.

Authors:  Fausto Petrelli; Diego Signorelli; Michele Ghidini; Antonio Ghidini; Elio Gregory Pizzutilo; Lorenzo Ruggieri; Mary Cabiddu; Karen Borgonovo; Giuseppina Dognini; Matteo Brighenti; Alessandro De Toma; Erika Rijavec; Marina Chiara Garassino; Francesco Grossi; Gianluca Tomasello
Journal:  Cancers (Basel)       Date:  2020-02-27       Impact factor: 6.639

8.  Biomarkers, Clinical Features, and Rechallenge for Immune Checkpoint Inhibitor Renal Immune-Related Adverse Events.

Authors:  Busra Isik; Mariam P Alexander; Sandhya Manohar; Lisa Vaughan; Lisa Kottschade; Svetomir Markovic; John Lieske; Aleksandra Kukla; Nelson Leung; Sandra M Herrmann
Journal:  Kidney Int Rep       Date:  2021-02-02

9.  Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.

Authors:  Frank B Cortazar; Zoe A Kibbelaar; Ilya G Glezerman; Ala Abudayyeh; Omar Mamlouk; Shveta S Motwani; Naoka Murakami; Sandra M Herrmann; Sandhya Manohar; Anushree C Shirali; Abhijat Kitchlu; Shayan Shirazian; Amer Assal; Anitha Vijayan; Amanda DeMauro Renaghan; David I Ortiz-Melo; Sunil Rangarajan; A Bilal Malik; Jonathan J Hogan; Alex R Dinh; Daniel Sanghoon Shin; Kristen A Marrone; Zain Mithani; Douglas B Johnson; Afrooz Hosseini; Deekchha Uprety; Shreyak Sharma; Shruti Gupta; Kerry L Reynolds; Meghan E Sise; David E Leaf
Journal:  J Am Soc Nephrol       Date:  2020-01-02       Impact factor: 10.121

Review 10.  Treatment of rheumatic immune-related adverse events due to cancer immunotherapy with immune checkpoint inhibitors-is it time for a paradigm shift?

Authors:  Katerina Chatzidionysiou; Matina Liapi; Georgios Tsakonas; Iva Gunnarsson; Anca Catrina
Journal:  Clin Rheumatol       Date:  2020-09-28       Impact factor: 3.650
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.